EMR — From orders to revenue
An order is a promise of work ahead, not the same thing as revenue already earned. That distinction makes Emerson's latest numbers interesting.
On November 4, $EMR reported fiscal fourth-quarter sales of $5.2 billion, up 7% from a year earlier. Underlying orders rose 14%, a measure that excludes currency translation and significant acquisitions and divestitures. Management pointed to demand for longer-cycle projects, including power, liquefied natural gas and aerospace.
Orders can indicate demand before a project produces sales, but the timing of delivery and the economics of each contract still matter. A full order book does not guarantee the same pace of future revenue or profit growth.
Emerson's reported earnings were $1.33 per share in the quarter, while adjusted earnings were $1.86. For fiscal 2027, management expects roughly 5% underlying sales growth. That is an outlook, not a result.
Watch whether the order momentum converts into delivered sales and operating cash flow over the next several quarters. Compare those figures with the company's forecast and segment margins: the payoff depends on what customers ultimately take delivery of and what Emerson earns on it.